Michael Alfieri, Principle Financial Officer at GENOCEA BIOSCIENCES, INC. (GNCA), bought 10,000 shares at $0.54 ($5K) on 2018-09-13, disclosed to the SEC on 2018-09-14.
Open-market purchase of $5k GNCA by Principle Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |